Our comprehensive – and constantly evolving – course portfolio provides hands-on experience of the most up-to-date bioinformatics techniques and resources, including clinical applications for researchers or healthcare professionals. We offer about 100 course-days per year. Gain high-quality introductory and advanced data science expertise in specific area. Our course portfolio can be tailored to meet the needs of your company as private courses, offered on-site or online: find out more about our specific offer for companies.
Training
Meet us at
What they say about us
SIB’s expertise has been invaluable to unlock the potential of our plant samples collection, which is being studied by our academic partners. Using the latest technology, SIB integrated information from various sources including taxonomy, mass spectrometry and biological results from 1600 plant extracts into a single, easy-to-use database, to support the search for drug candidates against tuberculosis and obesity.
Head of Green Mission Department, Pierre Fabre Laboratories
Collaborating with SIB has been a clear positive for our laboratory. The OncoBench ® programme that we developed together has greatly simplified our workflows and increased our efficiency, while preserving the security of our patients’ personal data.
Associate Physician and Unit Manager, Clinical Pathology Service, Geneva University Hospitals (HUG)
We pride ourselves on insisting on the highest standards of scientific rigour and the SIB proved to be an outstanding partner. Its leading expertise in bioinformatics and unique position as a not-for-profit organization made it an ideal partner for our first in-human clinical trial, which resulted in one of the highest-ranked publications to date in Nature Metabolism.
CEO and Co-Founder, Amazentis
The combination of QCMD’s EQA expertise and global network with SIB’s bioinformatics know-how will help shape the quality assessment schemes in this rapidly developing area of molecular diagnostics.
Technical Project Manager, QCMD
The collaboration allowed us to make the protein-protein interaction data from ENYO easily discoverable to all, through the fantastic knowledge platform dedicated to human proteins that is neXtProt. We are happy to contribute to enabling their use by all researchers studying and interpreting protein networks in health and disease.
Co-Founder, ENYO Pharma SA